In addition, a study on AD demonstrated that serum P-tau-181 was significantly positively correlated with CSF P-tau-181, suggesting that P-tau-181 in plasma should be of brain origin (Tatebe et al., 2017). The gene discussed is MAPT; the disease is Alzheimer disease.